Scientists have discovered a promising new method of treating depression using LSD and psilocin that does not involve hallucinations. These drugs affect a specific receptor in the brain, inducing antidepressant-like effects. Previous studies have shown that these compounds can relieve depression, but their hallucinogenic properties have limited their clinical use. Until recently, it was thought that their antidepressant and hallucinogenic effects were both due to serotonin receptor activation. However, a lab study found that LSD and psilocin bind to a molecule in the brain called the neurotrophic receptor tyrosine kinase (TrkB), which produces the antidepressant-like effects. This discovery paves the way for the development of new drugs that have fast and long-lasting antidepressant effects, without the hallucinogenic features of LSD and psilocin.
Denial of responsibility! TechCodex is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessory action within 24 hours.
Jessica Irvine is a tech enthusiast specializing in gadgets. From smart home devices to cutting-edge electronics, Jessica explores the world of consumer tech, offering readers comprehensive reviews, hands-on experiences, and expert insights into the coolest and most innovative gadgets on the market.